Igor Serov

Chief Financial Officer at HbO2 Therapeutics

Mr. Serov has over 20 years of experience in the Investment Banking industry. He spent most of his career in London running such groups as capital markets, structured products, and advisory. Mr. Serov has worked at Bankers Trust, Rose Square Capital, Dresdner Kleinwort Benson, and Renaissance Capital. Before joining Hemoglobin Oxygen Therapeutics, he was heading up coverage for corporate clients and financial institutions at Sberbank, the largest Russian bank. Mr. Serov has a BA in Mathematics and Economics from Connecticut College.

Location

Waltham, United States

Links


Org chart


Teams


Offices

This person is not in any offices


HbO2 Therapeutics

1 followers

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and manufacturer of oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body.


Industries

Employees

11-50

Links